PillRx only · Injection · Intravenous
Naxitamab
Brands: Danyelza · Naxitamab
2 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US2 NDCs
2 active makers
2 active makers
UKComing
soon
soon
CAComing
soon
soon
AUComing
soon
soon
EUComing
soon
soon
Medicaid dispensing volumeSDUD · per quarter
Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.
64
Rx · 2026 Q1
746
Units dispensed
-30%
Rx vs. year ago
5
Quarters · since 2025 Q1
Who makes it2 active · 0 exited
US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.
| Labeler | Type | Packages | Status |
|---|---|---|---|
| Y-mAbs Therapeutics, Inc. | unknown | 1 | SUPPLYING |
| BTG International Inc | unknown | 0 | SUPPLYING |
Regulatory & supply events
No recalls, shortages, or registration changes on record for this drug concept.